4//SEC Filing
ISIS PHARMACEUTICALS INC 4
Accession 0000874015-07-000049
$IONSCIK 0000874015operating
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:08 PM ET
Size
7.0 KB
Accession
0000874015-07-000049
Insider Transaction Report
Form 4
Wedel Mark K
VP & Chief Medical Officer
Transactions
- Other
Common Stock
2007-07-01$8.23/sh+902$7,422→ 7,505 total - Sale
Common Stock
2007-07-02$9.70/sh−902$8,752→ 6,603 total
Footnotes (2)
- [F1]Reporting 902 shares acquired under the Isis Pharmaceuticals, Inc. 2000 Employee Stock Purchase Plan on July 1, 2007.
- [F2]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/28/07.
Documents
Issuer
ISIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0000874015
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 5:08 PM ET
- Size
- 7.0 KB